Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB399276

Hepassocin/FGL1 Antibody (1016024) [DyLight 488], Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals FAB16142K

Catalog No. NB399276


Only null left
Add to Cart

Description

Description

Hepassocin/FGL1 Monoclonal antibody specifically detects Hepassocin/FGL1 in Human samples. It is validated for Flow Cytometry (Intracellular Staining), Immunocytochemistry, CyTOF
Specifications

Specifications

Hepassocin/FGL1
Monoclonal
DyLight 488
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry (Intracellular Staining), Immunocytochemistry, CyTOF
1016024
Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready
fibrinogen-like 1, fibrinogen-like protein 1, hepassocin, hepatocellular carcinoma-related sequence, Hepatocyte-derived fibrinogen-related protein 1, HFREP-1, HFREP1MGC12455, HP-041, LFIRE1, LFIRE-1, Liver fibrinogen-related protein 1
Mouse myeloma cell line NS0-derived recombinant human Hepassocin/FGL1, Met1-Ile312, Accession # BAB70690
0.1 mL
Cardiovascular Biology
2267
Store at 4°C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.